IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 217 filers reported holding IMMUNOMEDICS INC in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,345,000 | +47.3% | 86,381 | -38.6% | 0.05% | +35.9% |
| Q2 2020 | $4,985,000 | +149.7% | 140,643 | -5.0% | 0.04% | +95.0% |
| Q1 2020 | $1,996,000 | -46.8% | 148,082 | -16.5% | 0.02% | -28.6% |
| Q4 2019 | $3,751,000 | +87.5% | 177,270 | +17.5% | 0.03% | +75.0% |
| Q3 2019 | $2,001,000 | -23.6% | 150,893 | -20.1% | 0.02% | -23.8% |
| Q2 2019 | $2,620,000 | -23.6% | 188,914 | +5.8% | 0.02% | -25.0% |
| Q1 2019 | $3,430,000 | +42.3% | 178,578 | +5.7% | 0.03% | +40.0% |
| Q4 2018 | $2,410,000 | -33.5% | 168,894 | -2.9% | 0.02% | -16.7% |
| Q3 2018 | $3,622,000 | -7.5% | 173,893 | +5.2% | 0.02% | -7.7% |
| Q2 2018 | $3,914,000 | +44.5% | 165,362 | -10.8% | 0.03% | +271.4% |
| Q1 2018 | $2,709,000 | -18.4% | 185,415 | -9.7% | 0.01% | -12.5% |
| Q4 2017 | $3,320,000 | – | 205,380 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
| First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
| Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
| DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
| Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
| Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
| Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
| Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
| Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |